Sun, Feng
Bedenkov, Alexander
Liu, Bi-Cheng
Yang, Jiefu
Xu, Jin-fu
Ji, Linong
Zhou, Min
Zhang, Shaosen
Li, Xinli
Song, Yuanlin
Chen, Pingyan
Moreno, Carmen
Funding for this research was provided by:
AstraZeneca
Article History
Accepted: 3 March 2024
First Online: 4 April 2024
Declarations
:
: This work was supported by AstraZeneca, who established the Global Evidence Powerhub (GEP), and organized the External Advisory Committee (EAC) and the series meetings. All authors participated in the drafting, review, and approval of this publication. No honoraria or payments were made for authorship.
: The authors declare that they have no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: FS, PYC, AB, SSZ and CM designed the concept and drafted the outline of this manuscript. All EAC members contributed their insights to the content. All authors contributed to the drafting and critical review of the manuscript content and approved the final manuscript.